Submitted by Anonymous (not verified) on 28 January 2026 - 15:22
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 7, Status: Authorised